Matthew Napier
Matthew is a health economist specialising in economic evaluation, health policy, and medicine shortages.
He graduated from the University of Birmingham with a distinction in MSc health economics and health policy. In November 2022, following an internship at Takeda UK as a health economics intern, where he undertook his dissertation project, he joined OHE.
He has broad research experiences, including research into the socioeconomic burden of disease, the causes and consequences of medicine shortages, early economic evaluation, innovative payment methods, critical health policy issues, and the evaluation of ATMPs. He is a member of the value, affordability, and decision-making research theme at OHE.
Publications and Insights
- Publication: The Importance of Diversity of Supply in Rare Diseases Markets
- Publication: The Cost of Drug Shortages
- Insight: Drug shortages are on the rise – but what is their impact?
- Publication: A Framework for Value-aligned Pricing of Combination Therapies
- Insight: Using Target Product Profiles (TPPs) to improve diagnostic testing for cancer
- Publication: The Socioeconomic Burden Of Cervical Cancer in the UK: What are the benefits of achieving the WHO elimination target?
- Publication: The Dynamics of Drug Shortages
- Publication: Reimagining Prevention for a Healthier, More Prosperous Society
- Publication: Are Recommendations for HTA of Gene Therapies Being Achieved?